SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-074387
Filing Date
2024-06-17
Accepted
2024-06-17 17:15:55
Documents
2
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1568
2 EX-24.POA ntla-ex24_poa.htm EX-24.POA 9994
  Complete submission text file 0000950170-24-074387.txt   13030
Mailing Address C/O ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510
Business Address
Goff Brian (Reporting) CIK: 0001546216 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 241049270

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)